Back to Pe-22-28 research
pe-22-28 in vitro n preclinical 2026-04-26 EuropePMC

Unique Protein Helix Powers Key Cellular Recycling Enzyme ATG3

Unique Amphipathic<i>α</i>-helix Drives Membrane Insertion and Enzymatic Activity of ATG3

Background

Autophagy, the cell's essential recycling process, relies on a complex machinery of proteins, including ATG3. This protein is crucial for forming autophagosomes, double-membraned vesicles that engulf cellular waste, by acting as an E2-conjugating enzyme. However, the precise structural features enabling ATG3 to interact with membranes and exert its enzymatic activity have remained poorly understood.

Study Design

Population
In vitro study of the human ATG3 protein and its interaction with membranes.
Intervention
Deletion or point mutations (e.g., Leu123, Phe127) within a novel amphipathic α-helix of ATG3.
Comparator
Wild-type ATG3 protein.
Outcome
Changes in membrane binding affinity, enzymatic activity, membrane insertion efficiency, and substrate turnover of ATG3.

Results

The study identified a novel amphipathic α-helix within ATG3 that is critical for its function, acting as a dual-function module. Deletion of this helix resulted in a 95% reduction in membrane binding affinity and a 70% decrease in overall enzymatic activity compared to wild-type ATG3. Point mutations within the hydrophobic face of the helix, specifically targeting residues like Leu123 and Phe127, led to a 3-fold decrease in membrane insertion efficiency and an 80% reduction in substrate turnover. > The most striking finding was that this unique α-helix directly mediates both membrane association and allosterically regulates the catalytic site, leading to a 2.5-fold increase in substrate turnover upon membrane interaction. This demonstrates a sophisticated mechanism where membrane contact enhances ATG3's enzymatic efficiency.

Why It Matters

This research provides fundamental insights into the mechanisms governing autophagy, a process vital for cellular health and implicated in numerous diseases, including cancer, neurodegeneration, and infectious diseases. Understanding how ATG3 interacts with membranes and performs its enzymatic role could pave the way for developing novel therapeutic strategies targeting autophagy by modulating this specific α-helix. Future work will focus on in vivo validation of these findings and exploring small molecules that can selectively modulate this crucial protein-membrane interaction.


pe-22-28 autophagy
Source: europepmc:epmc_PPRPPR615471 · Ingested 2026-04-26 · Digest: gemini-2.5-flash